Sphera Funds Management’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

Sphera Funds Management’s Portfolio VINC Stock Details VINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,523	Closed	-$93K	–	91
2022 Q2	$93K	Sell	3,523 -32,485	-90%	-$1.44M	0.01%	57
2022 Q1	$2.88M	Hold	36,008	–	–	0.41%	51
2021 Q4	$7.34M	Buy	36,008 +3,279	+10%	+$818K	0.81%	42
2021 Q3	$10.6M	Buy	32,729 +21,356	+188%	+$6.23M	0.89%	33
2021 Q2	$2.96M	Buy	11,373 +6,688	+143%	+$2.04M	0.2%	93
2021 Q1	$1.81M	Buy	4,685 +2,362	+102%	+$953K	0.14%	115
2020 Q4	$972K	Buy	+2,323	New	+$732K	0.09%	98

Other funds holding VINC

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

SRC

Sage Rhino Capital Menlo Park, California $617M AUM 28.74% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Sphera Funds Management's VINC Position: Q3 2022 in Review

Sphera Funds Management sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q3 2022, closing a stake of 3,523 shares — an estimated $93K sold.

Sphera Funds Management first reported a position in VINC in Q4 2020 and held it in 7 quarters. The position peaked at $10.6M in Q3 2021. 42 funds tracked by Wall St. Rank hold VINC as of Q3 2022.

Sphera Funds Management reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Sphera Funds Management sold 3,523 Vincerx Pharma, Inc. Common Stock shares in Q3 2022, an estimated $93K.
Sphera Funds Management first reported a position in Vincerx Pharma, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
Sphera Funds Management's Vincerx Pharma, Inc. Common Stock position peaked at $10.6M in Q3 2021.
42 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q3 2022.

Based on Sphera Funds Management's 13F filing for Q3 2022, filed 14 Nov 2022.